Clinical trial

Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer

NCT03081481

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-06-07

PhasePHASE2

Study timeline

Study start (actual)2017-06-07Date precision: day

Registry last updated2019-04-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

PRX302DRUG

Sponsors & collaborators

Sophiris Bio Corplead sponsor

Mapped research locations

LondonUnited Kingdom2 New YorkNew York, United States1 BaltimoreMaryland, United States1 OcalaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03081481 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.